2015 Executive Compensation Summary for Intersect ENT, Inc. Officers

Contract Categories: Human Resources › Compensation Agreements
Summary

This document outlines the 2015 compensation terms for key executives of Intersect ENT, Inc., including the President & CEO, CFO, COO, and VP of Sales. It specifies each executive's base salary, stock option grants, and target bonus as a percentage of base salary. Stock options vest over four years with a six-month cliff, and bonuses are awarded at the Compensation Committee's discretion based on company performance. The agreement is effective January 1, 2015.

Read More Arrow
EX-10.1 2 d858673dex101.htm EX-10.1 EX-10.1

Exhibit 10.1

 

Name and Position

    Fiscal year
2015 Base
Salary (1)		      Number of
Shares
subject to
option
grant (2)		      Target
Bonus for
Performance
in 2015
(Percentage of
Base Salary) (3)		  

Lisa D. Earnhardt,

President & Chief Executive Officer

    $ 430,000        150,000         50 % 

Jeryl L. Hilleman

Chief Financial Officer

    $ 345,100        50,000         40 % 

Richard E. Kaufman,

Senior Vice President & Chief Operating Officer

    $ 312,500        25,000         35 % 

Robert H. Binney, Jr.,

Vice President, Sales

    $ 219,400        25,000         50 % 

Notes:

 

(1) Effective January 1, 2015.
(2) Granted by the Compensation Committee on January 21, 2015. The exercise price per share of such option grant is $21.06, the closing price of the Company’s common stock on the NASDAQ Global Market on the date of grant. The shares subject to each option vest commencing January 1, 2015 in equal monthly installments over four years following a six month cliff vesting period.
(3) The actual bonus to be awarded will be at the Compensation Committee’s discretion based on the Company’s performance against specified corporate milestones determined by the Compensation Committee.